Patents by Inventor Wilson S. Meng

Wilson S. Meng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Particle formulations of all-trans retinoic acid and transforming growth factor beta for the treatment of type 1 diabetes mellitus
    Patent number: 10105334
    Abstract: Particle formulations are disclosed that include polymeric particles containing a small molecule drug and a high molecular weight therapeutic protein. Methods of making and using the particle formulations also are disclosed. These particle formulations are of use to treat an autoimmune disease, such as diabetes, or an inflammatory disease.
    Type: Grant
    Filed: January 16, 2015
    Date of Patent: October 23, 2018
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Duquesne University
    Inventors: Nick Giannoukakis, Massimo M. Trucco, Wilson S. Meng
  • PARTICLE FORMULATIONS OF ALL-TRANS RETINOIC ACID AND TRANSFORMING GROWTH FACTOR BETA FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS
    Publication number: 20160338984
    Abstract: Particle formulations are disclosed that include polymeric particles containing a small molecule drug and a high molecular weight therapeutic protein. Methods of making and using the particle formulations also are disclosed. These particle formulations are of use to treat an autoimmune disease, such as diabetes, or an inflammatory disease.
    Type: Application
    Filed: January 16, 2015
    Publication date: November 24, 2016
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, Duquesne University
    Inventors: Nick Giannoukakis, Massimo M. Trucco, Wilson S. Meng